The mitochondrial respiratory complex I is a target for 15-deoxy-Δ12,14-prostaglandin J2 action

Journal of Lipid Research

Volumn 46, Issue 4, 2005, Pages 736-743

  Martinez B ^a   Perez Castillo A ^b   Santos, A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b CSIC   (Spain)

Author keywords

Cyclopentenone prostaglandins; Reactive oxygen species; Respiratory chain

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); 15 DEOXYPROSTAGLANDIN J2; 15-DEOXYPROSTAGLANDIN J2; DRUG DERIVATIVE; ENZYME INHIBITOR; OXYGEN; PROSTAGLANDIN D2;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; ENZYME ACTIVITY; ENZYME INHIBITION; MITOCHONDRION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; WISTAR RAT;

ANIMALS; ELECTRON TRANSPORT COMPLEX I; ENZYME INHIBITORS; MITOCHONDRIA; OXYGEN; OXYGEN CONSUMPTION; PROSTAGLANDIN D2; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES;

EID: 21744455741     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M400392-JLR200     Document Type: Article

References (44)

1. Fukushima, M. 1990. Prostaglandin J2-anti-tumour and anti-viral activities and the mechanisms involved. Eicosanoids. 3: 189-199.
2. Straus, D. S., and C. K. Glass. 2001. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med. Res. Rev. 21: 185-210.
3. Na, H. K., and Y. J. Surh. 2003. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation. Biochem. Pharmacol. 66: 1381-1391.
4. 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell. 83: 803-812.
5. Kliewer, S. A., J. M. Lenhard, T. M. Willson, I. Patel, D. C. Morris, and J. M. Lehmann. 1995. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell. 83: 813-819.
6. Dreyer, C., G. Krey, H. Keller, F. Givel, G. Helftenbein, and W. Wahli. 1992. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 68: 879-887.
7. Kliewer, S. A., B. M. Forman, B. Blumberg, E. S. Ong, U. Borgmeyer, D. J. Mangelsdorf, K. Umesono, and R. M. Evans. 1994. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA. 91: 7355-7359.
8. Hashimoto, K., R. T. Ethridge, and B. M. Evers. 2002. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells. Int. J. Gastrointest. Cancer. 32: 7-22.
9. Laurora, S., S. Pizzimenti, F. Briatore, A. Fraioli, M. Maggio, P. Reffo, C. Ferretti, M. U. Dianzani, and G. Barrera. 2003. Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells. J. Pharmacol. Exp. Ther. 305: 932-942.
10. 12,14- prostaglandin J2-induced apoptosis in breast cancer cells. J. Biol. Chem. 276: 47131-47135.
11. Patel, L., I. Pass, P. Coxon, C. P. Downes, S. A. Smith, and C. H. Macphee. 2001. Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN. Curr. Biol. 11: 764-768.
12. Pignatelli, M., C. Cocca, A. Santos, and A. Perez-Castillo. 2003. Enhancement of BRCA1 gene expression by the peroxisome proliferator-activated receptor gamma in the MCF-7 breast cancer cell line. Oncogene. 22: 5446-5450.
13. Zander, T., J. A. Kraus, C. Grommes, U. Schlegel, D. Feinstein, T. Klockgether, G. Landreth, J. Koenigsknecht, and M. T. Heneka. 2002. Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma. J. Neurochem. 81: 1052-1060.
14. Elstner, E., C. Muller, K. Koshizuka, E. A. Williamson, D. Park, H. Asou, P. Shintaku, J. W. Said, D. Heber, and H. P. Koeffler. 1998. Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc. Natl. Acad. Sci. USA. 95: 8806-8811.
15. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 225-260.
16. Rossi, A., P. Kapahi, G. Natoli, T. Takahashi, Y. Chen, M. Karin, and M. G. Santoro. 2000. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature. 403: 103-108.
17. 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc. Natl. Acad. Sci. USA. 97: 4844-4849.
18. Ikeda, Y., A. Sugawara, Y. Taniyama, A. Uruno, K. Igarashi, S. Arima, S. Ito, and K. Takeuchi. 2000. Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor gamma in macrophages via an interaction with NRF2. J. Biol. Chem. 275: 33142-33150.
19. 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils. J. Immunol. 168: 3563-3569.
20. 12,14-prostaglandin J2 binds to and activates H-Ras. Proc. Natl. Acad. Sci. USA. 100: 4772-4777.
21. 12,l4-prostaglandin J2. J. Biol. Chem. 278: 51251-51260.
22. Kondo, M., T. Oya-Ito, T. Kumagai, T. Osawa, and K. Uchida. 2001. Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress. J. Biol. Chem. 276: 12076-12083.
23. 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors. J. Biol. Chem. 276: 38152-38158.
24. Bureau, F., C. Desmet, D. Melotte, F. Jaspar, C. Volanti, A. Vanderplasschen, P. P. Pastoret, J. Piette, and P. Lekeux. 2002. A proinflammatory role for the cyclopentenone prostaglandins at low micromolar concentrations: oxidative stress-induced extracellular signal-regulated kinase activation without NF-kappa B inhibition. J. Immunol. 168: 5318-5325.
25. Lennon, A. M., M. Ramauge, A. Dessouroux, and M. Pierre. 2002. MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-Delta(12,14) -prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive oxygenated species. J. Biol. Chem. 277: 29681-29685.
26. Huang, W. C., C. C. Chio, K. H. Chi, H. M. Wu, and W. W. Lin. 2002. Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-Delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929. Exp. Cell Res. 277: 192-200.
27. Nencioni, A., K. Lauber, F. Grunebach, L. Van Parijs, C. Denzlinger, S. Wesselborg, and P. Brossart. 2003. Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling. J. Immunol. 171: 5148-5156.
28. Dunkley, P. R., J. W. Heath, S. M. Harrison, P. E. Jarvie, P. J. Glenfield, and J. A. Rostas. 1988. A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: homogeneity and morphology of subcellular fractions. Brain Res. 441: 59-71.
29. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
30. Black, M. J., and R. B. Brandt. 1974. Spectrofluorometric analysis of hydrogen peroxide. Anal. Biochem. 58: 246-254.
31. Darley-Usmar, V. M. 1987. The molecular aetiology of human mitochondrial myopathies. Biochem. Soc. Trans. 15: 102-103.
32. Casas, F., L. Domenjoud, P. Rochard, R. Hatier, A. Rodier, L. Daury, A. Bianchi, P. Kremarik-Bouillaud, P. Becuwe, J. Keller, H. Schohn, C. Wrutniak-Cabello, G. Cabello, and M. Dauca. 2000. A 45 kDa protein related to PPARgamma2, induced by peroxisome proliferators, is located in the mitochondrial matrix. FEBS Lett. 478: 4-8.
33. Rossi, A., G. Elia, and M. G. Santoro. 1996. 2-Cyclopenten-1-one, a new inducer of heat shock protein 70 with antiviral activity. J. Biol. Chem. 271: 32192-32196.
34. Fukushima, M. 1992. Biological activities and mechanisms of action of PGJ2 and related compounds: an update. Prostaglandins Leukot. Essent. Fatty Acids. 47: 1-12.
35. Cocco, T., M. Di Paola, S. Papa, and M. Lorusso. 1999. Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation. Free Radic. Biol. Med. 27: 51-59.
36. Di Paola, M., T. Cocco, and M. Lorusso. 2000. Ceramide interaction with the respiratory chain of heart mitochondria. Biochemistry. 39: 6660-6668.
37. Cadenas, F., A. Boveris, C. I. Ragan, and A. O. Stoppani. 1977. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch. Biochem. Biophys. 180: 248-257.
38. Liu, Y., G. Fiskum, and D. Schubert. 2002. Generation of reactive oxygen species by the mitochondrial electron transport chain. J. Neurochem. 80: 780-787.
39. Kudin, A. P., N. Y. Bimpong-Buta, S. Vielhaber, C. E. Elger, and W. S. Kunz. 2004. Characterization of superoxide-producing sites in isolated brain mitochondria. J. Biol. Chem. 279: 4127-4135.
40. Pignatelli, M., J. Sanchez-Rodriguez, A. Santos, and A. Perez-Castillo. 2005. 15-Deoxy-(Delta)-12,14-prostaglandin J2 induces programmed cell death of breast cancer cells by a pleiotropic mechanism. Carcinogenesis. 26: 81-92.
41. Mueller, E., M. Smith, P. Sarraf, T. Kroll, A. Aiyer, D. S. Kaufman, W. Oh, G. Demetri, W. D. Figg, X. P. Zhou, G. Eng, B. M. Spiegelman, and P. W. Kantoff. 2000. Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. Proc. Natl. Acad. Sci. USA. 97: 10990-10995.
42. Pignatelli, M., M. Cortes-Canteli, C. Lai, A. Santos, and A. Perez-Castillo. 2001. The peroxisome proliferator-activated receptor gamma is an inhibitor of ErbBs activity in human breast cancer cells. J. Cell Sci. 114: 4117-4126.
43. Colville-Nash, P. R., S. S. Qureshi, D. Willis, and D. A. Willoughby. 1998. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1. J. Immunol. 161: 978-984.
44. Kawamoto, Y., Y. Nakamura, Y. Naito, Y. Torii, T. Kumagai, T. Osawa, H. Ohigashi, K. Satoh, M. Imagawa, and K. Uchida. 2000. Cyclopentenone prostaglandins as potential inducers of phase II detoxification enzymes. 15-Deoxy-Delta(12,14)-prostaglandin J2-induced expression of glutathione S-transferases. J. Biol. Chem. 275: 11291-11299.